Publikasi

Pfizer launches Elranatamab in India for relapsed or re...

BCMA-directed bispecific antibody is available as a fixed-dose subcutaneous inj...

Aragen manufactures first GMP batches of Daretabart

Technology transfer moves anti-GD2 monoclonal antibody programme from Californi...

When things go wrong, Densura is here for you

When complaints, claims or regulatory investigations arise, having the right sup...

Nutrify Today launches Eurasia Sumflex in Tashkent

Three-day event brings together nearly 3,000 stakeholders as Nutrify Today posi...

Attacking Gout: Crystalys Sees Room for Its Dotinurad a...

First-patient dosing in AMETHYST comes five days after a Crystalys rival, Swedis...

Organ Chips Move Towards Mainstream Drug Development, w...

From spaceflight to high-throughput studies, evidence supports greater use of or...

Targeted Protein Degradation Broadens Its Scope

Advancing targeted protein degradation (TPD) depends on a coordinated ecosystem ...

Pharma’s Trial Problem: Outdated Systems, Broken Data, ...

In this thought leadership article, Erik Terjesen of Silicon Foundry explores ho...

Top 10 U.S. Biopharma Clusters 2026

Mid-cap buyers, improved capital raising climate, and reshoring of manufacturing...

Turning the Patent Cliff into a Bioplant Opportunity

Using duckweed as an alternative to mammalian expression systems can ease manufa...

Neuropixels Opto Integrates Electrophysiology and Optog...

Neuropixels Opto is a single brain probe combining electrophysiology and optogen...

University of Minnesota Breaks Ground on New Community-...

University of Minnesota leaders and faculty, state officials, clinic staff and p...

Endocrine Society’s Recent Advocacy Accomplishments – J...

Endocrine Society Advocacy Victories – Join Endocrine Society Advocacy Campaigns...

China has approved the world’s first invasive brain-com...

One day last October, sitting in the courtyard of his house in China’s Henan pro...

From Discovery to Development in Emerging Modalities

ProBio is building flexible platforms for multispecific antibodies, ADCs, and ot...

Multiomics Mass Spec Workflows in Drug Discovery

Advances in end-to-end multiomics platforms and the underlying scientific knowle...